FDA GOOD REVIEW PRACTICES COMMITTEE WILL BREAK INTO GROUPS
This article was originally published in The Tan Sheet
Executive Summary
FDA GOOD REVIEW PRACTICES COMMITTEE WILL BREAK INTO GROUPS to begin development of an "action plan" at a meeting set for Nov. 21, the agency said. The meeting also will feature discussion of "the results of the initial workshops" and will "solicit input on the project from staff involved in the review of INDs, NDAs, and PLAs," FDA said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: